deltatrials
Recruiting PHASE1 INTERVENTIONAL 5-arm NCT06995482

Multiple Ascending Dose Study to Evaluate the Safety, Tolerability and Pharmacokinetics of KSHN001034 in Healthy Postmenopausal Female Volunteers

A Phase 1, Open Label, Randomized, Multiple Ascending Dose (MAD) Study Evaluating the Safety, Tolerability and Pharmacokinetics of KSHN001034 in Healthy Postmenopausal Female Volunteers

Sponsor: Clinexcel Research, Ahmedabad, India

Conditions Healthy Postmenopausal Women
Interventions Fulvestrant KSHN001034
Updated 2 times since 2025 Last updated: Feb 10, 2026 Started: Aug 18, 2025 Primary completion: May 31, 2026 Completion: Jun 30, 2026
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE1 clinical study on Healthy Postmenopausal Women, this trial is actively recruiting participants. The trial is conducted by Clinexcel Research, Ahmedabad, India and has accumulated 2 data snapshots since 2025. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

~Jun 2025 – ~Feb 2026 · 8 months · monthly snapshotNot Yet Recruiting~Feb 2026 – present · 5 months · monthly snapshotRecruiting

Change History

2 versions recorded

  1. Feb 2026 — Present [monthly]

    Recruiting PHASE1

    Status: Not Yet Recruiting → Recruiting

  2. Jun 2025 — Feb 2026 [monthly]

    Not Yet Recruiting PHASE1

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Clinexcel Research, Ahmedabad, India
  • Eric Solutions LLC
  • Kashiv BioSciences, LLC
Data source: Kashiv BioSciences, LLC

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations